List of Publications and Communications

Done in the context of the Target-Therapy project

PUBLICATIONS

1. Youf, R.; Müller, M.; Balasini, A.; Thétiot, F.; Müller, M.; Hascoët, A.; Jonas, U.; Schönherr, H.; Lemercier, G.; Montier, T.; Le Gall, T. Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies. Pharmaceutics 2021, 13, 1995. Open access; Twitter; LinkedIn; Encyclopedia 

2. Le Gall, T.; Berchel, M.; Davies, L.; Mottais, A.; Ghanem, R.; Fautrel, A.; Gill, D.; Hyde, S.; Lehn, P.; Lehn, J.-M.; Lemiègre, L.; Benvegnu, T.; Jaffrès, P.-A.; Pitard, B.; Montier, T. Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes. Pharmaceutics 2022, 14, 25. Open access; Encyclopedia

3. Youf, R.; Nasir, A.; Müller, M.; Thétiot, F.; Haute, T.; Ghanem, R.; Jonas, U.; Schönherr, H.; Lemercier, G.; Montier, T.; Le Gall, T. Ruthenium(II) Polypyridyl Complexes for Antimicrobial Photodynamic Therapy: Prospects for Application in Cystic Fibrosis Lung Airways. Pharmaceutics 2022, 14(8), 1664; Open access

4. Youf, R.; Ghanem, R.; Nasir, A.; Lemercier, G.; Montier, T.; Le Gall, T. Impact of mucus and biofilm on antimicrobial photodynamic therapy: Evaluation using Ruthenium(II) complexes. Biofilm 2023, 5, 100113; Open access

5. Kaur, K.; Müller, M.; Müller, M.; Schönherr H. Photodynamic Eradication of Pseudomonas aeruginosa with Ru-Photosensitizers Encapsulated in Enzyme Degradable Nanocarriers. Pharmaceutics 2023, 15(12), 2683; Open access

COMMUNICATIONS

Poster presentations

1. Ru(II)-polypyridyl complexes as linear and nonlinear photosensitizers in (a-)PDT. Sylviane Chevreux, Raphaëlle Youf, Tony Le Gall, Franck Thétiot, Mareike Müller, Ulrich Jonas, Holger Schönherr, Tristan Montier, and Gilles Lemercier. 2021 FrenchBIC meeting, 10-13 October 2021, Obernai (France)

2. Ru(II)-polypyridyl complexes as linear and nonlinear photosensitizers in (a-)PDT. Sylviane Chevreux, Raphaëlle Youf, Tony Le Gall, Franck Thétiot, Mareike Müller, Ulrich Jonas, Holger Schönherr, Tristan Montier, and Gilles Lemercier. 4ème Journées GDR HappyBIO – SFPb - SFPMed, 24-26 November 2021, Toulouse (France)

3. Investigation of antibacterial photodynamic therapy using Ruthenium(II) polypyridyl complexes under experimental conditions mimicking cystic fibrosis lung infections, Raphaëlle Youf, Franck Thétiot, Mareike Müller, Ulrich Jonas, Holger Schönherr, Tristan Montier, Gilles Lemercier, and Tony Le Gall, SF-NANO 7th annual meeting, 6-8 December 2021, Angers (France)

4. Detailed Evaluation of Ruthenium(II) Polypyridyl Complexes as Photosensitizers in Antibacterial Photodynamic Therapy Using Clinical Strains. Raphaëlle Youf, Sylviane Chevreux, Franck Thétiot, Ulrich Jonas, Holger Schönherr, Tristan Montier, Gilles Lemercier, and Tony Le Gall. Journées scientifiques de l’école doctorale biologie santé, 9 December 2021, Brest (France)

5. Ruthenium(II) polypyridyl complexes for antibiofilm photodynamic therapy: Assessment using Pseudomonas aeruginosa and Staphylococcus aureus clinical isolates. Raphaëlle Youf, Adeel Nasir, Mareike Müller, Franck Thétiot, Ulrich Jonas, Holger Schönherr, Gilles Lemercier, Tristan Montier, and Tony Le Gall. EuroBioFilms 2022, 31 August to 3 September 2022, Palma, Mallorca (Balearic Islands)

6. Antimicrobial photodynamic therapy with Ru(II)-loaded polymer nanocarriers towards treatment of chronic bacterial lung infections: Proof-of-concept using cystic fibrosis Pseudomonas aeruginosa isolates. Kawaljit Kaur, Max Müller, Gilles Lemercier, Raphaëlle Youf, Tristan Montier, Tony Le Gall, Holger Schönherr, and Mareike Müller. ECFS 2023, 7-10 June 2023, Vienna (Austria). ePoster Presentation

7. Photo-éradication ciblée de bactéries résistantes aux antimicrobiens : Intérêt pour un traitement des infections respiratoires dans la mucoviscidose. Margaux Bonnardot, Adeel Nasir, Ali Balasini, Franck Thétiot, Ulrich Jonas, Gilles Lemercier, Tristan Montier, et Tony Le Gall. Colloque des jeunes chercheurs VLM, 6 Februray 2024, Institut Pasteur, Paris (France)

Oral presentations

1. Detailed Evaluation of Ruthenium(II) Polypyridyl Complexes as Photosensitizers in Antibacterial Photodynamic Therapy Using Clinical Strains. Raphaëlle Youf, Sylviane Chevreux, Franck Thétiot, Ulrich Jonas, Holger Schönherr, Tristan Montier, Gilles Lemercier, and Tony Le Gall. PDD-PDT 2020, 5-6 November 2020, Virtual conference (online)

2. Ruthenium(II) polypyridyl complexes for antibacterial photodynamic therapy using clinical strains: a follow-up study. Raphaëlle Youf, Sylviane Chevreux, Franck Thétiot, Ulrich Jonas, Holger Schönherr, Tristan Montier, Gilles Lemercier, and Tony Le Gall. AEBIN Photochemistry school 2020, 7-9 September 2020, Virtual summer school (online)

3. La thérapie photodynamique (PDT) comme stratégie antimicrobienne contre les infections pulmonaires : preuve de concept pour la mucoviscidose. Raphaëlle Youf, Sylviane Chevreux, Franck Thétiot, Ulrich Jonas, Holger Schönherr, Tristan Montier, Gilles Lemercier, and Tony Le Gall. Colloque des jeunes chercheurs VLM, 5 March 2021, Institut Pasteur, Paris (France)

4. TARGET-THERAPY Project: Spatially targeted eradication of antimicrobial-resistant bacteria: Novel polymer-based photodynamic therapy following aerosol lung delivery. Tony Le Gall, AMR.2 Kick-off Meeting, 22 April 2021, 2nd French-German call for projects on antimicrobial resistance 2020, Virtual meeting (online)

5. Prospects of Ruthenium(II) Polypyridyl Complexes for Application in Cystic Fibrosis Lung Airways: Influence of Environmental Conditions in Antimicrobial Photodynamic Therapy. Raphaëlle Youf, Adeel Nasir, Mareike Müller, Franck Thétiot, Tanguy Haute, Rosy Ghanem, Ali Balasini, Ulrich Jonas, Holger Schönherr, Gilles Lemercier, Tristan Montier, and Tony Le Gall. PDT PDD 2022, 24-28 October 2022, Nancy (France)

6. Towards spatially targeted eradication of antimicrobial-resistant bacteria: novel polymer-based antimicrobial photodynamic therapy. Kawaljit Kaur, Max Müller, Raphaëlle Youf, Mareike Müller, Gilles Lemercier, Tony Le Gall, Tristan Montier, and Holger Schönherr. POLY-CHAR 2023, 23-26 January 2023, Auckland (New Zealand). Awarded as one of the three best young researcher's oral presentation

7. Targeted antimicrobial photodynamic therapy: Controlled delivery of light for spatial eradication of antimicrobial resistant pathogens. Margaux Bonnardot, Adeel Nasir, Mareike Müller, Franck Thétiot, Gilles Lemercier, Ulrich Jonas, Holger Schönherr, Tristan Montier, and Tony Le Gall. IBSAM 2023, 8 June 2023, Brest (France). Poster + Flash presentations 

8. Target-Therapy project review. Holger Schönherr and Tony Le Gall. French-German Calls for Projects on Antimicrobial Resistance: Final Review Meeting, 4-5 March 2024, Rösrath-Forsbach (Germany)

9. Pulmonary antimicrobial photodynamic therapy: comparison of two clinically-approved nebulizers to deliver ruthenium(II) polypyridyl complex and curcumin. Adeel Nasir, Margaux Bonnardot, Franck Thétiot, Antony Memboeuf, Ali Balasini, Gilles Lemercier, Ulrich Jonas, Tristan Montier, and Tony Le Gall. PDT PDD 2024, 16-20 September 2024, Kochel am See (Germany)

Upcoming CommunicationS

1. Towards pulmonary antimicrobial photodynamic therapy using Ruthenium-based photosensitizers: Interests - Feasibility - Opportunities. Tony Le Gall et al. GDR HappyBio, 28-30 October 2024, Paris (France)

2. Comparison of two clinical nebulizers for delivering photosensitizers: a prospective study towards antibacterial photodynamic therapy against cystic fibrosis lung infections. Margaux Bonnardot et al. 18th European Young Investigators Meeting, 26-28 February 2025, Paris (France)